KR930007452A - 벤조디아제핀-금단 환자의 불안증 치료방법 - Google Patents
벤조디아제핀-금단 환자의 불안증 치료방법 Download PDFInfo
- Publication number
- KR930007452A KR930007452A KR1019920019562A KR920019562A KR930007452A KR 930007452 A KR930007452 A KR 930007452A KR 1019920019562 A KR1019920019562 A KR 1019920019562A KR 920019562 A KR920019562 A KR 920019562A KR 930007452 A KR930007452 A KR 930007452A
- Authority
- KR
- South Korea
- Prior art keywords
- anxiety
- pharmacologically acceptable
- bmy
- patients
- benzodiazepines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
본 발명에 따라, 불안증에 시달리는 벤조디아제핀-금단 환자들에게 BMY 14802; 화학적으로 4-〔4-(5-플루오로-2-피리미디닐)-1-피페라지닐〕-1-(4-플루오로페닐)부탄올, 또는 바람직하게는 그의 R-(+)-에 난티오머를 투여하는 것으로 되는, 벤조디아제핀-금단 환자의 불안증 치료방법이 제공된다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (7)
- 벤조디아제핀 투약치료가 중단된 환자의 불안증 치료방법에 있어서, 불안증으로 시달리는 이들 환자에게 BMY 14802나 약리적으로 허용되는 그의 산부가염 및/또는 수화물을 불안해소에 유효한 양으로 투여하는 것이 특징인, 벤조디아제핀 투약치료 금단환자의 불안증 치료방법.
- 제1항에 있어서 BMY 14802의 약리적으로 허용되는 산부가염이 히드로클로라이드염인 것이 특징인 방법.
- 제1항에 있어서 BMY 14802의 투여를 경구 투여경로로 행하는 것이 특징인 방법.
- 벤조디아제핀 투약치료가 중단된 환자의 불안증 치료방법에 있어서, 불안증으로 시달리는 이들 환자에게 BMY 14802의 R-(+)-에난티오머나 약리적으로 허용되는 그의 산부가염 및/또는 수화물을 불안해소에 유효한 양으로 투여하는 것이 특징인, 벤조디아제핀 투약치료 금단환자의 불안증 치료방법.
- 제1항에 있어서, BMY 14802 또는 약리적으로 허용되는 그의 염 및/또는 수화물과 약리적으로 허용되는 담체로 된 제약 조성물을 투여하는 것이 특징인 방법.
- 제5항에 있어서, BMY 14802의 R-(+)-에난티오머 또는 약리적으로 허용되는 그의 염 및/또는 수화물과의 약리적으로 허용되는 담체로된 것이 특징인 방법.
- 불안증에 시달리는 벤조디아제핀-금단 환자들의 불안증 치료용 약제제조를 위한, BMY 14802, 또는 약리적으로 허용되는 그의 산부가염 및/또는 수화물의 용도.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78201091A | 1991-10-24 | 1991-10-24 | |
US782,010 | 1991-10-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR930007452A true KR930007452A (ko) | 1993-05-20 |
KR100196334B1 KR100196334B1 (ko) | 1999-06-15 |
Family
ID=25124656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019920019562A KR100196334B1 (ko) | 1991-10-24 | 1992-10-23 | 벤조디아제핀-금단환자의 불안증 치료용 조성물 |
Country Status (18)
Country | Link |
---|---|
US (1) | US5278164A (ko) |
EP (1) | EP0538897B1 (ko) |
JP (1) | JPH05238934A (ko) |
KR (1) | KR100196334B1 (ko) |
AT (1) | ATE150645T1 (ko) |
AU (1) | AU649169B2 (ko) |
CA (1) | CA2081062A1 (ko) |
CY (1) | CY2019A (ko) |
DE (1) | DE69218544T2 (ko) |
DK (1) | DK0538897T3 (ko) |
ES (1) | ES2101000T3 (ko) |
GR (1) | GR3022945T3 (ko) |
HK (1) | HK113897A (ko) |
IL (1) | IL103499A0 (ko) |
OA (1) | OA09766A (ko) |
PH (1) | PH30028A (ko) |
TW (1) | TW217382B (ko) |
ZA (1) | ZA928105B (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011091418A1 (en) * | 2010-01-25 | 2011-07-28 | Northeastern University | Screening method for adverse side effects of a therapeutic pharmaceutical drug |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4605655A (en) * | 1984-03-06 | 1986-08-12 | Bristol-Myers Company | Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives |
US5055470A (en) * | 1989-06-01 | 1991-10-08 | Bristol-Myers Squibb Co. | Method of treatment of ischemia in brain |
-
1992
- 1992-10-21 CA CA002081062A patent/CA2081062A1/en not_active Abandoned
- 1992-10-21 AU AU27165/92A patent/AU649169B2/en not_active Ceased
- 1992-10-21 IL IL103499A patent/IL103499A0/xx unknown
- 1992-10-21 TW TW081108399A patent/TW217382B/zh active
- 1992-10-22 PH PH45145A patent/PH30028A/en unknown
- 1992-10-22 OA OA60291A patent/OA09766A/en unknown
- 1992-10-22 ZA ZA928105A patent/ZA928105B/xx unknown
- 1992-10-22 JP JP4324571A patent/JPH05238934A/ja not_active Ceased
- 1992-10-23 DE DE69218544T patent/DE69218544T2/de not_active Expired - Fee Related
- 1992-10-23 EP EP92118219A patent/EP0538897B1/en not_active Expired - Lifetime
- 1992-10-23 DK DK92118219.2T patent/DK0538897T3/da active
- 1992-10-23 AT AT92118219T patent/ATE150645T1/de not_active IP Right Cessation
- 1992-10-23 ES ES92118219T patent/ES2101000T3/es not_active Expired - Lifetime
- 1992-10-23 KR KR1019920019562A patent/KR100196334B1/ko not_active IP Right Cessation
-
1993
- 1993-06-01 US US08/069,654 patent/US5278164A/en not_active Expired - Lifetime
-
1997
- 1997-03-27 GR GR970400379T patent/GR3022945T3/el unknown
- 1997-06-26 HK HK113897A patent/HK113897A/xx not_active IP Right Cessation
-
1998
- 1998-02-20 CY CY201998A patent/CY2019A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE69218544D1 (de) | 1997-04-30 |
AU649169B2 (en) | 1994-05-12 |
GR3022945T3 (en) | 1997-06-30 |
JPH05238934A (ja) | 1993-09-17 |
ATE150645T1 (de) | 1997-04-15 |
US5278164A (en) | 1994-01-11 |
PH30028A (en) | 1996-11-08 |
AU2716592A (en) | 1993-04-29 |
EP0538897B1 (en) | 1997-03-26 |
HK113897A (en) | 1997-08-29 |
CA2081062A1 (en) | 1993-04-25 |
OA09766A (en) | 1993-11-30 |
IL103499A0 (en) | 1993-03-15 |
DK0538897T3 (da) | 1997-08-25 |
ES2101000T3 (es) | 1997-07-01 |
EP0538897A1 (en) | 1993-04-28 |
TW217382B (ko) | 1993-12-11 |
DE69218544T2 (de) | 1997-11-13 |
ZA928105B (en) | 1993-08-25 |
CY2019A (en) | 1998-02-20 |
KR100196334B1 (ko) | 1999-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900015730A (ko) | 정신장해 치료방해 | |
HUP0203325A2 (hu) | Biciklusos aminosavak, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
ATE292982T1 (de) | Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten | |
ATE185268T1 (de) | Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin | |
ES2164040T1 (es) | Uso de agonistas del sitio de union de la glicina o de inhibidores de la absorcion de la glicina para el tratamiento de trastornos neuropsiquiatricos. | |
KR950703951A (ko) | 광학적으로 순수한 r-케토로락을 포함하는 조성물과 무통과 해열치료에 이를 사용하는 방법(antipyretic and analgesic methods and compositions containing optically pure r-ketorolac) | |
DE60316779D1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
JP2001510795A5 (ko) | ||
RU95101385A (ru) | Продукты, содержащие g-csf и tnf связующие протеина | |
KR970025615A (ko) | 암 전이 억제제 | |
NO20005912L (no) | Sulfonylsyre- eller sulfonylamino-N-(heteroaralkyl)- azaheterocyklylamidforbindelser | |
KR930003915A (ko) | 장기 이식에 있어서의 거부 반응 치료 약제 | |
RU2003125274A (ru) | Применение флумазенила в производстве лекарства для лечения алкогольной зависимости | |
ATE198278T1 (de) | Verwendung von sulodexid und von arzneimitteln, die dieses enthalten, zur behandlung der diabetischen nephropathie | |
RU2002122084A (ru) | Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных растройств | |
KR890003390A (ko) | 골다공증 및 관련된 장해의 치료방법 | |
ATE546136T1 (de) | Kardioprotektions- und neuroprotektionsverfahren durch intravenöse verabreichung von halogenierten flüchtigen narkosemitteln | |
BR0211855A (pt) | Medicamento e método para tratamento e melhoria da qualidade restauradora do sono | |
BR0009380A (pt) | Tratamento de câncer melhorado comtemozolomida | |
KR910015300A (ko) | 부스피론 : 수면 무호흡증의 치료용도 | |
KR940013503A (ko) | 동맥경화증의 예방 또는 치료용 약제학적 조성물 | |
KR930007452A (ko) | 벤조디아제핀-금단 환자의 불안증 치료방법 | |
ATE228843T1 (de) | Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit | |
HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására | |
Neill | Postoperative analgesia following brachial plexus block |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20040205 Year of fee payment: 6 |
|
LAPS | Lapse due to unpaid annual fee |